Marker Therapeutics to Present at the Virtual Oppenheimer 31st Annual Healthcare Conference
HOUSTON, March 15, 2021 /PRNewswire/ -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its President and Chief Executive Officer, Peter L. Hoang, will present at the upcoming Virtual Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:10 p.m. ET.
A live webcast of the presentation will be accessible from the Investors section of the company's website at markertherapeutics.com and will be available for replay following the event.
About Marker Therapeutics, Inc.
To receive future press releases via email, please visit: https://www.markertherapeutics.com/email-alerts.
View original content to download multimedia:http://www.prnewswire.com/news-releases/marker-therapeutics-to-present-at-the-virtual-oppenheimer-31st-annual-healthcare-conference-301246974.html
SOURCE Marker Therapeutics, Inc.
Company Codes: NASDAQ-NMS:MRKR